FDA Adverse Event Injury Summary report: N

UNKNOWN EGIA TRI STAPLE

MDR report key: 11996144 · Received June 14, 2021

Report

Report Number
1219930-2021-02349
Event Type
Injury
Date Received
June 14, 2021
Date of Event
June 1, 2020
Report Date
June 14, 2021
Manufacturer
COVIDIEN LP LLC NORTH HAVEN
Product Code
GDW
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TITLE: POSTOPERATIVE RISK OF PANCREATIC FISTULA AFTER DISTAL PANCREATECTOMY WITH OR WITHOUT SPLEEN PRESERVATION SOURCE: TUMORI JOURNAL 2021, VOL. 107(2) 160¿165. ACCEPTED: 1 JUNE 2020. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ACCORDING TO THE LITERATURE, A STUDY COMPARED THE OUTCOMES OF PATIENTS WHO UNDERWENT DISTAL PANCREATECTOMY WITH AND WITHOUT SPLENECTOMY BETWEEN JANUARY 2011 AND DECEMBER 2017. 48 PATIENTS WERE INCLUDED IN THE STUDY: 26 UNDERWENT DISTAL PANCREATECTOMY WITH SPLENECTOMY (DPS) AND 22 UNDERWENT SPLEEN PRESERVING DISTAL PANCREATECTOMY (SPDP). THE ENDOSCOPIC STAPLER RELOAD WAS USED FOR PANCREATIC TRANSECTION IN 33 PATIENTS. THE ENDOSCOPIC STAPLER WAS USED FOR THE SPLENIC ARTERY AND VEIN IN PATIENTS UNDERGOING SPLENECTOMY. THERE WERE 3 CONVERSIONS TO OPEN SURGERY IN THE DPS GROUP DUE TO INTRAOPERATIVE BLEEDING FROM THE SPLENIC ARTERY. TRANSFUSION WAS NEEDED DUE TO THE INTRAOPERATIVE BLOOD LOSS. THERE WERE 15 POSTOPERATIVE PANCREATIC FISTULA (POPF) WITH 2 PATIENTS, 1 FROM EACH GROUP, THAT REQUIRED INTERVENTION. IN OTHER 13 PATIENTS WITH POPF, 3 WERE TREATED BY MAINTAINING THE SURGICAL DRAINAGE FOR LESS THAN 3 WEEKS; WHILE 7 AND 3 PATIENTS REQUIRED ENDOSCOPIC OR PERCUTANEOUS DRAINAGE, RESPECTIVELY. POSTOPERATIVE PANCREATIC HEMORRHAGE OCCURRED IN 3 PATIENTS IN THE DPS GROUP AND 1 IN THE SPDP GROUP. 2 REQUIRED REOPERATIONS; THE OTHER CASES WERE TREATED WITH PERCUTANEOUS DRAINAGE. THERE WAS 1 WOUND INFECTION AND 4 INTRAABDOMINAL ABSCESSES IN THE DPS GROUP. THERE WERE 6 AND 9 BIOCHEMICAL LEAKAGE IN THE DPS AND SPDF GROUP, RESPECTIVELY. THE LENGTH OF HOSPITAL STAY IN DPS GROUP WAS LONGER DUE TO THE HIGHER RATE POPF.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
886179 UNKNOWN EGIA TRI STAPLE STAPLE, IMPLANTABLE GDW COVIDIEN LP LLC NORTH HAVEN UNKNOWN EGIA TRI STAPLE

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention